Orthopaedic Implants Worth Rs 70L Seized By FDA

Nagpur: The Food and Drug Administration (FDA) team seized orthopaedic implants worth around Rs 70 lakh from a stockist during a raid at Dhantoli last week. The implants, mostly imported, were stocked without licences.

The team, under supervision of FDA joint commissioner (drug), Viraj Paunikar, served a notice to the stockist to furnish bills and invoices within three days.

The team comprising drug inspectors Neeraj Lohkare, Prashant Ramteke, Manish Chaudhuri and Shehnaz Taji acted on a tip-off and took action.

“If the stockist provides us bills and invoices, only then the seized materials would be considered legally procured items, else there he would be prosecuted for the irregularity,” said an official adding most of the seized implants were meant to be sent to different private hospitals.

Related Posts

  • Pharma
  • January 21, 2025
  • 74 views
Biocon urges govt to exempt cancer, rare-disease drugs from tax in Budget

India should eliminate tax on drugs for cancer treatment and for chronic and rare diseases, the chairperson of major drugmaker Biocon Ltd said ahead of Prime Minister Narendra Modi’s budget…

  • Pharma
  • January 21, 2025
  • 107 views
Glenmark Pharma share rises 2% as unit launches blood clotting drug

Glenmark Pharmaceuticals share price:Pharmaceutical major Glenmark Pharmaceuticals shares rose up to 2.23 per cent to hit an intraday high of Rs 1,537.90 per share on Tuesday, January 21, 2025. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Biocon urges govt to exempt cancer, rare-disease drugs from tax in Budget

Biocon urges govt to exempt cancer, rare-disease drugs from tax in Budget

Glenmark Pharma share rises 2% as unit launches blood clotting drug

Glenmark Pharma share rises 2% as unit launches blood clotting drug

Fire breaks out at pharmaceutical company in Andhra Pradesh, no casualty

Fire breaks out at pharmaceutical company in Andhra Pradesh, no casualty

Pharma body to cap prices of cigarette substitutes, seeks data

Pharma body to cap prices of cigarette substitutes, seeks data